Health Products

Lipase OSR6x30, Uric Acid OSR6x98, and Enzymatic Creatinine OSR6x204 (2018-08-27)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
More than 10 numbers, contact manufacturer.
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
B. Uric Acid OSR6x98OSR6X98
1508
Manufacturer
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
C. Enzymatic Creatinine OSR6x204OSR6X204
More than 10 numbers, contact manufacturer.
Manufacturer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES
A. Lipase OSR6x30OSR6X30

Introduction

Affected products

A. Lipase OSR6x30
B. Uric Acid OSR6x98
C. Enzymatic Creatinine OSR6x204

Reason

NAPQI (N-Acetyl-p-benzoquinone imine), a metabolite of Acetaminophen, causes negative interference with enzymatic creatinine OSR6X204, Lipase OSR6X30 and uric acid OSR6x98 assays, at levels present in the serum/plasma of overdose patients. NAPQI in toxic concentrations may potentially lead to erroneously low results for enzymatic creatinine, lipase and uric acid.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime